Bishal Gyawali, Associate Professor at Queen’s University, shared Marathon of Hope Cancer Centres Network’s post on LinkedIn:
“It was my pleasure to discuss with MOHCCN Patient Working Group members Beverley Riediger and Dan Murphy about the intersection of Common Sense Oncology and Precision Omcology. Our discussion topics include CSO, precision medicine, dose optimization, quality of life, and questions patients need to ask while making treatment decisions.”
Quoting Marathon of Hope Cancer Centres Network’s post:
“New episode of Network Voices Conversations out now!
We all know the importance of delivering the right treatment to the right patient at the right time.
But what about choosing the right dose and the right duration?
In this episode, MOHCCN Patient Working Group members Beverley Riediger and Dan Murphy speak with Dr. Bishal Gyawali about common sense oncology—an approach that helps patients and clinicians choose treatments that reduce toxicity, lower costs and optimize quality of life.
They discuss why common sense oncology is essential to precision medicine, how researchers can measure quality of life and what questions patients and caregivers should ask when considering a new treatment.”
Check out their full conversation
Other articles featuring Bishal Gyawali and Marathon of Hope Cancer Centres Network